CA
NZ
UK
AU
IND
US
Novavax (NASDAQ:NVAX), a protein-based vaccine maker with a Sanofi partnership, rose USD 1.74 to USD 12.75 in the October 9, 2026 session. Working back from the published change, the prior close was about USD 11.01. Volume of 6.199M shares was about 1.2 times the …
Picard Medical's 6.65 percent pre-market decline to 9.48 dollars arrives with a 14-day RSI of 70.5, a reading in overbought territory that typically follows a period of strong recent buying rather than signaling a new downtrend on its own. That context fits the stock's …
● BAX closed at $24.33 on 9 October 2026, with two data sets disagreeing sharply on the average analyst target, at $21.73 and $28.73.
● BDX closed at $183.69 on 9 October 2026, and the $185.07 consensus target implies upside of only about 0.8%.
● Agilent shares closed at $170.75 on 9 October 2026, and the second data set's $175.20 mean target implies upside of about 2.6%.
● ABBV closed at $276.24 on 9 October 2026, with the second data set's $282.61 average target implying about 2.3% upside.
● ABT closed at $99.71 on 9 October 2026, and the $118.88 consensus target implies upside of roughly 19.2%.
● ALGN closed at $142.71 on 9 October 2026, and published averages of about $199 appear out of step with recent named targets of $155 to $209.
● VRXA closed Friday, October 9, 2026, at $1.300, up 19.27%, among the stronger small-cap biotechnology movers.
● XRTX closed Friday, October 9, 2026, at $1.410, down 23.78%, against a session in which healthcare was strong.
Please wait processing your request...